A wireless magnetoelectric-driven strategy to boost nose-to-brain drug delivery with сore-shell nanotransducers; Journal of Controlled Release; Vol. 389

Bibliografiske detaljer
Parent link:Journal of Controlled Release.— .— Amsterdam: Elsevier Science Publishing Company Inc.
Vol. 389.— 2026.— Article number 114421, 22 p.
Institution som forfatter: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий
Andre forfattere: Chernozem R. V. Roman Viktorovich, Romashchenko A. V. Aleksandr Viktorovich, Chernozem P. V. Polina Viktorovna, Urakova A. O. Alina Olegovna, Koptsev D. A. Danila Andreevich, Surmeneva M. A. Maria Alexandrovna, Grubova I. Yu. Irina Yurievna, Wagner D. V. Dmitry, Gerasimov E. Yu. Evgeny, Solovjeva O. I. Olga Igorevna, Razumov I. A. Ivan Alekseevich, Morozova K. N. Kseniya, Kiseleva E. Elena, Sharapova M. B. Marina Borisovna, Zuev D. S. Daniil Sergeevich, Silvanovich E. K. Elizaveta Konstantinovna, Ibraeva A. Zh. Azhar Zhangeldinovna, Vechkapova S. O. Svetlana Olegovna, Kazantsev S. O. Sergey Olegovich, Lozhkomoev A. S. Aleksandr Sergeevich, Surmenev R. A. Roman Anatolievich
Summary:Title screen
Targeted therapeutic delivery to specific regions of the central nervous system (CNS) is a promising approach for treating localized pathologies such as neuropathic pain or viral infections. The systemic administration of drugs is often inefficient, as it distributes medication throughout the body, including non-targeted CNS areas, rather than concentrating it in the affected neural tissues. Leveraging axonal transport for targeted drug delivery could enable precise therapeutic interventions, such as antiviral, antineuropathic, or regenerative treatments, selectively directed to specific ganglia or CNS cells. In this study, we developed a novel strategy using magnetoelectric (ME) nanotransducers based on the core-shell MnFe2O4@Ba0.85Ca0.15Zr0.1Ti0.9O3 nanoparticles (MFO@BCZT NPs), which exhibit an exceptionally high ME response (12.2 × 105 mV·cm−1·Oe−1), to facilitated axonal transport of cargoes from the nasal cavity to the brain by a low-intensity alternating magnetic field (0–50 Hz, 0–30 mT). Firstly, in vitro experiments demonstrated that MFO@BCZT NPs efficiently activated voltage-gated calcium channels in primary neurons under safe magnetic stimulation. Ex vivo studies further confirmed enhanced cellular uptake of MFO@BCZT NPs and their ability for effective wireless stimulation of mouse hippocampal slices. Finally, in vivo experiments revealed significant ME-mediated improvement of axonal transport of BSA-Cy7 from nasal cavity into the mouse brain using MFO@BCZT NPs. This study establishes a non-invasive ME nanoplatform for spatiotemporally controlled neuronal logistics, offering a transformative approach for targeted therapeutic delivery to CNS
Текстовый файл
AM_Agreement
Sprog:engelsk
Udgivet: 2026
Fag:
Online adgang:https://doi.org/10.1016/j.jconrel.2025.114421
Format: Electronisk Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=687882

MARC

LEADER 00000naa0a2200000 4500
001 687882
005 20260901112001.0
090 |a 687882 
100 |a 20260901d2026 k||y0rusy50 ba 
101 0 |a eng 
102 |a NL 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a A wireless magnetoelectric-driven strategy to boost nose-to-brain drug delivery with сore-shell nanotransducers  |f Roman V. Chernozem, Alexander V. Romashchenko, Polina V. Chernozem [et al.] 
203 |a Текст  |b визуальный  |c электронный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 147 tit 
330 |a Targeted therapeutic delivery to specific regions of the central nervous system (CNS) is a promising approach for treating localized pathologies such as neuropathic pain or viral infections. The systemic administration of drugs is often inefficient, as it distributes medication throughout the body, including non-targeted CNS areas, rather than concentrating it in the affected neural tissues. Leveraging axonal transport for targeted drug delivery could enable precise therapeutic interventions, such as antiviral, antineuropathic, or regenerative treatments, selectively directed to specific ganglia or CNS cells. In this study, we developed a novel strategy using magnetoelectric (ME) nanotransducers based on the core-shell MnFe2O4@Ba0.85Ca0.15Zr0.1Ti0.9O3 nanoparticles (MFO@BCZT NPs), which exhibit an exceptionally high ME response (12.2 × 105 mV·cm−1·Oe−1), to facilitated axonal transport of cargoes from the nasal cavity to the brain by a low-intensity alternating magnetic field (0–50 Hz, 0–30 mT). Firstly, in vitro experiments demonstrated that MFO@BCZT NPs efficiently activated voltage-gated calcium channels in primary neurons under safe magnetic stimulation. Ex vivo studies further confirmed enhanced cellular uptake of MFO@BCZT NPs and their ability for effective wireless stimulation of mouse hippocampal slices. Finally, in vivo experiments revealed significant ME-mediated improvement of axonal transport of BSA-Cy7 from nasal cavity into the mouse brain using MFO@BCZT NPs. This study establishes a non-invasive ME nanoplatform for spatiotemporally controlled neuronal logistics, offering a transformative approach for targeted therapeutic delivery to CNS 
336 |a Текстовый файл 
371 0 |a AM_Agreement 
461 1 |t Journal of Controlled Release  |c Amsterdam  |n Elsevier Science Publishing Company Inc. 
463 1 |t Vol. 389  |v Article number 114421, 22 p.  |d 2026 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a Magnetoelectric nanotransducers 
610 1 |a Biocompatible nanomaterials 
610 1 |a Magnetic resonance imaging 
610 1 |a Wireless electrostimulation 
610 1 |a Intranasal administration 
610 1 |a Nose-to-brain drug delivery 
610 1 |a Neuronal modulation 
701 1 |a Chernozem  |b R. V.  |c physicist  |c Associate Professor of Tomsk Polytechnic University  |f 1992-  |g Roman Viktorovich  |9 19499 
701 1 |a Romashchenko  |b A. V.  |g Aleksandr Viktorovich  |f 1986-  |c biologist  |c Associate Professor of Tomsk Polytechnic University, Candidate of biological sciences  |9 88955 
701 1 |a Chernozem  |b P. V.  |c specialist in the field of informatics and computer technology  |c Research Engineer of Tomsk Polytechnic University  |f 1997-  |g Polina Viktorovna  |9 22733 
701 1 |a Urakova  |b A. O.  |c specialist in the field of material science  |c Laboratory assistant of Tomsk Polytechnic University  |f 2002-  |g Alina Olegovna  |9 88596 
701 1 |a Koptsev  |b D. A.  |c specialist in the field of material science  |c Laboratory assistant of Tomsk Polytechnic University  |f 2003-  |g Danila Andreevich  |9 88597 
701 1 |a Surmeneva  |b M. A.  |c specialist in the field of material science  |c engineer-researcher of Tomsk Polytechnic University, Associate Scientist  |f 1984-  |g Maria Alexandrovna  |9 15966 
701 1 |a Grubova  |b I. Yu.  |c physicist  |c engineer-researcher of Tomsk Polytechnic Universit  |f 1989-  |g Irina Yurievna  |9 16573 
701 1 |a Wagner  |b D. V.  |g Dmitry 
701 1 |a Gerasimov  |b E. Yu.  |g Evgeny 
701 1 |a Solovjeva  |b O. I.  |g Olga Igorevna 
701 1 |a Razumov  |b I. A.  |g Ivan Alekseevich 
701 1 |a Morozova  |b K. N.  |g Kseniya 
701 1 |a Kiseleva  |b E.  |g Elena 
701 1 |a Sharapova  |b M. B.  |g Marina Borisovna 
701 1 |a Zuev  |b D. S.  |g Daniil Sergeevich 
701 1 |a Silvanovich  |b E. K.  |g Elizaveta Konstantinovna 
701 1 |a Ibraeva  |b A. Zh.  |g Azhar Zhangeldinovna  |f 2000-  |c biologist  |c Laboratory assistant of Tomsk Polytechnic University  |9 88957 
701 1 |a Vechkapova  |b S. O.  |g Svetlana Olegovna 
701 1 |a Kazantsev  |b S. O.  |c specialist in the field of material science  |c engineer of Tomsk Polytechnic University  |f 1991-  |g Sergey Olegovich  |9 18951 
701 1 |a Lozhkomoev  |b A. S.  |c specialist in the field of medical technology  |c researcher of Tomsk Polytechnic University  |f 1982-  |g Aleksandr Sergeevich  |9 18056 
701 1 |a Surmenev  |b R. A.  |c physicist  |c Associate Professor of Tomsk Polytechnic University, Senior researcher, Candidate of physical and mathematical sciences  |f 1982-  |g Roman Anatolievich  |9 15957 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий  |c (2017- )  |9 28334 
801 0 |a RU  |b 63413507  |c 20260901 
850 |a 63413507 
856 4 0 |u https://doi.org/10.1016/j.jconrel.2025.114421  |z https://doi.org/10.1016/j.jconrel.2025.114421 
942 |c CF